Protective role of curcumin in disease progression from non-alcoholic fatty liver disease to hepatocellular carcinoma: a meta-analysis
Frontiers in Pharmacology · 19.01.2024 · 15
DOI: 10.3389/fphar.2024.1343193 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Frontiers in Pharmacology, online erschienen am 19.01.2024. Verfasst von Yubing Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Chi…. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Sichuan Province Science and Technology Support Program.
Abstract (Originalsprache)
Background
Pathological progression from non-alcoholic fatty liver disease (NAFLD) to liver fibrosis (LF) to hepatocellular carcinoma (HCC) is a common dynamic state in many patients. Curcumin, a dietary supplement derived from the turmeric family, is expected to specifically inhibit the development of this progression. However, there is a lack of convincing evidence.
Methods
The studies published until June 2023 were searched in PubMed, Web of Science, Embase, and the Cochrane Library databases. The SYstematic Review Center for Laboratory animal Experimentation (SYRCLE) approach was used to evaluate the certainty of evidence. StataSE (version 15.1) and Origin 2021 software programs were used to analyze the critical indicators.
Results
Fifty-two studies involving 792 animals were included, and three disease models were reported. Curcumin demonstrates a significant improvement in key indicators across the stages of NAFLD, liver fibrosis, and HCC. We conducted a detailed analysis of common inflammatory markers IL-1β, IL-6, and TNF-α, which traverse the entire disease process. The research results reveal that curcumin effectively hinders disease progression at each stage by suppressing inflammation. Curcumin exerted hepatoprotective effects in the dose range from 100 to 400 mg/kg and treatment duration from 4 to 10 weeks. The mechanistic analysis reveals that curcumin primarily exerts its hepatoprotective effects by modulating multiple signaling pathways, including TLR4/NF-κB, Keap1/Nrf2, Bax/Bcl-2/Caspase 3, and TGF-β/Smad3.
Conclusion
In summary, curcumin has shown promising therapeutic effects during the overall progression of NAFLD–LF–HCC. It inhibited the pathological progression by synergistic mechanisms related to multiple pathways, including anti-inflammatory, antioxidant, and apoptosis regulation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Department of Obstetrics, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Health Care Office of the Service Bureau of Agency for Offices Administration of the Central Military Commission, Beijing, China.
- TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Förderung
- National Natural Science Foundation of China
- Sichuan Province Science and Technology Support Program
Zitieren
APA
Li, Y., Deng, X., Tan, X., Li, Q., Yu, Z., Wu, W., Ma, X., Zeng, J., & Wang, X. (2024). Protective role of curcumin in disease progression from non-alcoholic fatty liver disease to hepatocellular carcinoma: a meta-analysis. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1343193
Vancouver
Li Y, Deng X, Tan X, Li Q, Yu Z, Wu W, et al. Protective role of curcumin in disease progression from non-alcoholic fatty liver disease to hepatocellular carcinoma: a meta-analysis. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1343193
BibTeX
@article{Li2024,
author = {Li, Yubing and Deng, Xinyu and Tan, Xiyue and Li, Qianrong and Yu, Zhi and Wu, Wenbin and Ma, Xiao and Zeng, Jinhao and Wang, Xiaoyin},
title = {Protective role of curcumin in disease progression from non-alcoholic fatty liver disease to hepatocellular carcinoma: a meta-analysis},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1343193}
}
EUVIMED